Invention Grant
- Patent Title: Hydrophilic/lipophilic polymeric matrix dosage formulation
- Patent Title (中): 亲水/亲脂性聚合物基质剂型
-
Application No.: US11717502Application Date: 2007-03-12
-
Publication No.: US07927624B2Publication Date: 2011-04-19
- Inventor: Guy Vergnault , Pascal Grenier , Lauretta Maggi , Ubaldo Conte
- Applicant: Guy Vergnault , Pascal Grenier , Lauretta Maggi , Ubaldo Conte
- Applicant Address: CH Muttenz
- Assignee: Jagotec AG
- Current Assignee: Jagotec AG
- Current Assignee Address: CH Muttenz
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Agent David E. Johnson, Esq.; Muriel Liberto, Esq.
- Priority: ITMI2000A0852 20000414; ITMI2000A1963 20000907
- Main IPC: A61K31/40
- IPC: A61K31/40 ; A61K9/20 ; A61K9/22 ; A61K9/24
Abstract:
An oral dosage form comprising a pharmaceutical tablet of one or more layers, one of which carries a biologically active substance; the formulation of said tablet includes different percentages of hydrophilic and lipophilic polymeric materials, and adjuvant substances. The tablets of the present invention show a release rate which is independent from the amounts of active substance present in the tablet.
Public/Granted literature
- US20070264336A1 Hydrophilic/lipophilic polymeric matrix dosage formulation Public/Granted day:2007-11-15
Information query
